>

Boon Koh - Agilent Technologies Non-Executive Independent Chairman of the Board

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:6em;padding-top: 0px;;'>A</div>
A -- USA Stock  

Fiscal Quarter End: April 30, 2020  

  Chairman
Mr. Koh Boon Hwee is an Independent Chairman of the Board of Agilent Technologies, Inc. Mr. Koh is the managing partner of Credence Capital Fund II Ltd., a private equity fund. Mr. Koh has served as the nonExecutive Chairman of Sunningdale Tech Ltd. since January 2009 and previously served as its Executive Chairman and Chief Executive Officer from July 2005 to January 2009. He has served as the nonExecutive Chairman of Yeo Hiap Seng Ltd. since April 2010, the nonExecutive Chairman of Rippledot Capital Advisers Pte. Ltd. since February 2011 and the nonExecutive Chairman of Far East Orchard Ltd. since April 2013. He served as Executive Director of MediaRing Limited from February 2002 to August 2009 Chairman of DBS Bank Ltd. from January 2006 to April 2010 Chairman of Singapore Airlines from July 2001 to December 2005 and Chairman of Singapore Telecom from April 1992 to August 2001. Mr. Koh spent fourteen years with HewlettPackard Company in its Asia Pacific region. Mr. Koh possesses a strong mix of leadership and operational experience from his various senior positions with Sunningdale Tech, AAC Technologies, MediaRing Limited, DBS Bank, Singapore Airlines and Singapore Telecom. In addition, Mr. Koh has deep experience in the Asia Pacific region and brings that knowledge and perspective to the Board. Mr. Koh has extensive experience with our company and its predecessor, HewlettPackard, having served on our board for over 10 years and having spent 14 years with HewlettPackard.
Age: 68  Chairman Since 2017      
408 345-8474  www.agilent.com

Boon Koh Latest Insider Activity

Management Efficiency

The company has return on total asset of 0.11 % which means that for every 100 dollars spent on asset it generated profit of $0.11. This is way below average. Similarly, it shows return on equity (ROE) of 0.17 % implying that it made 0.17 on every $100 invested by shareholders.
The company has accumulated 2.41 B in total debt with debt to equity ratio (D/E) of 50.6 implying that the company may be unable to produce cash to meet its debt commitments. Agilent Technologies has Current Ratio of 1.5 which is considered satisfactory as compared to similar companies.

Similar Executives

Found 8 records

CHAIRMAN Since

Kevin ConroyExact Sciences Corporation
2014
Yoav ShakedDarioHealth Corp
2018
Yutaka NiiharaEMMAUS LIFE SCIENCES INC NEW
2019
Willis LeeEMMAUS LIFE SCIENCES INC NEW
2019
David KingLaboratory Corporation Of Ameri
2019
Jonathan LordDexCom
2015
Terrance GreggDexCom
2015
Erez RaphaelDarioHealth Corp
2018

Company Summary

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 16300 people.Agilent Technologies (A) is traded on BATS Exchange in USA. It is located in 5301 Stevens Creek Blvd., Santa Clara, CA 95051, United States and employs 16,300 people. Agilent Technologies is listed under Measuring and Control Equipment category by Fama And French industry classification.

Agilent Technologies Leadership Team

Daniel Podolsky, Independent DirectorView
Hans Bishop, Independent DirectorView
George Scangos, Independent DirectorView
Sue Rataj, Independent DirectorView
Jacob Thaysen, Senior Vice President, President - Life Sciences and Applied Markets GroupView
Samraat Raha, Senior Vice President, President - Diagnostics and Genomics GroupView
Mark Doak, Senior Vice President, President - Agilent CrossLab GroupView
Paul Clark, Independent DirectorView
Mala Anand, Independent DirectorView
Robert McMahon, Chief Financial Officer, Senior Vice PresidentView
Ankur Dhingra, Investor RelationsView
Hajime Tada, Interim General CounselView
James Cullen, Independent Non-Executive Chairman of the BoardView
Michael McMullen, CEO and President Director and Member of Executive CommitteeView
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. UnitView
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate ControllershipView
Henrik AncherJensen, Senior Vice President and Presidentident - Order FulfillmentView
Dow Wilson, Independent DirectorView
Heidi Kunz, Independent DirectorView
Dominique Grau, Senior Vice President - Human ResourcesView
Heidi Fields, Independent DirectorView
Michael Tang, Senior Vice President General Counsel, SecretaryView
Alicia Rodriguez, Vice President - Investor RelationsView
Tadataka Yamada, Independent DirectorView
Didier Hirsch, CFO and Sr. VPView
Boon Koh, Non-Executive Independent Chairman of the BoardView
Robert Herbold, Independent DirectorView

Stock Performance Indicators

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Agilent Technologies Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Agilent Technologies and Global Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Please continue to Trending Equities. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.